ACTRN12624000995572尚未招募Unknown
Evaluate the Feasibility and Safety of Transplantation of Unsuitable Livers following Long-term Normothermic Perfusion for Adult Liver Transplant Recipient
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Suitable potential LT-NMP trial graft recipients will be identified during their assessment and listing process. Eligible patients will be informed that they would be suitable to receive a graft from the NEOP trial. They will be given the patient information sheets to read more about the trial. If already listed, potential recipients will be identifiedt, contacted and sent the information documents. Informed consent will be obtained from all participants. Enrolling in the trial will not impact the chance of them receiving a standard ‘transplantable’ graft. Patients with all aetiologies of chronic liver disease will be considered for inclusion.
- •Recipients will meet all the following inclusion criteria to be eligible for participation in the NEOP trial:
- •Adult primary liver transplant recipient.
- •Patient listed electively (not ‘super-urgent) for transplantation.
- •Low to moderate transplant risk candidate, suitable for extended criteria grafts, as assessed by the ANLTU liver transplant listing multidisciplinary team (MDT) meeting (these are usually candidates with MELD score < 20, without cardiovascular comorbidities, with good functional and nutrition status, with patent portal vein and with no history of previous major upper abdominal surgery, for example, patients transplanted for liver cancer).
- •Able to undergo the informed consent process.
排除标准
- •Recipient exclusion criteria
- •Subjects who meet any of the following exclusion criteria are excluded from participating in the NEOP trial:
- •‘High-risk patients’ not considered suitable for a marginal graft (these are mainly patients with high MELD score (>20) with cardiovascular comorbidities or renal insufficiency, with poor nutrition and performance status).
- •Patients with extensive portal vein thrombosis diagnosed prior to the transplantation.
- •Liver re-transplantation.
- •Patients with fulminant hepatic failure.
- •Patients undergoing transplantation of more than one organ.
研究者
相似试验
招募中
1 期
Study of safety and efficacy of transplantation of platelet extracted mitochondria in heart ischemic stroke, Clinical trial phase 1 and 2IRCT20210920052524N1Rasht University of Medical Sciences34
尚未招募
不适用
A study to evaluate the safety of transplantation therapy using microspheroids assembled by peripheral nerve-derived adult stem cells in acute,sub-acute spinal cord injury patientsInjury, poisoning and certain other consequences of external causesKCT0007731Yonsei University Health System, Severance Hospital6
已完成
不适用
Safety and efficacy of transplantation of tissue-engineered autologous oral mucosal epithelial cell sheets in preventing formation of strictures after endoscopic submucosal dissection for esophageal cancersuperficial esophageal cancerJPRN-UMIN000010251Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences10
已完成
不适用
To assess the safety and feasibility of administering Dexamphetamine after stroke and its effect on cerebral and cardiac haemodynamicsCerebral infarctionISRCTN36285333niversity of Nottingham (UK)42
已完成
不适用
Safety investigation of simultaneous injection of olfactory ensheathing cells and mesenchymal stem cells in treatment of spinal cord injuryIRCT20160110025930N2Tarbiat Modares University10